Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?

被引：75
|
作者：
Gauci, Marie-Lea [1 ,2 ]
Baroudjian, Barouyr [1 ,2 ]
Zeboulon, Charlotte [1 ,2 ]
Pages, Cecile [1 ,2 ]
Pote, Nicolas [3 ,4 ]
Roux, Olivier [5 ]
Bouattour, Mohamed [6 ]
Lebbe, Celeste [1 ,2 ]
机构：
[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France
[2] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM U976, Paris, France
[3] Hop Beaujon, AP HP, Dept Anatomopathol, Clichy, France
[4] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM UMR 1149, Paris, France
[5] Hop Beaujon, AP HP, Dept Hepatol & Reanimat Hepat, Clichy, France
[6] Hop Beaujon, AP HP, Dept Oncol Digest, 100 Blvd Gen Leclerc, F-92110 Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 69卷 / 02期
关键词：
IPILIMUMAB; NIVOLUMAB;
D O I：
10.1016/j.jhep.2018.03.034
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：548 / 550
页数：4
相关论文
共 50 条
  • [1] Pharmacogenomics for immunotherapy and immune-related cardiotoxicity
    Castrillon, Jessica A.
    Eng, Charis
    Cheng, Feixiong
    HUMAN MOLECULAR GENETICS, 2020, 29 (R2) : R186 - R196
  • [2] Predictors of immunotherapy-induced immune-related adverse events
    Kartolo, A.
    Sattar, J.
    Sahai, V
    Baetz, T.
    Lakoff, J. M.
    CURRENT ONCOLOGY, 2018, 25 (05) : E403 - E410
  • [3] Immune-Related Adverse Effects of Cancer Immunotherapy - Implications for Rheumatology
    Cappelli, Laura C.
    Shah, Ami A.
    Bingham, Clifton O., III
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (01) : 65 - +
  • [4] Immunotherapy - immune-related adverse events and their management
    Petrausch, Ulf
    THERAPEUTISCHE UMSCHAU, 2019, 76 (04) : 195 - 198
  • [5] Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis
    Lowes, Kristina
    Reinecke, Johanna
    Brunner, Marius
    Scholz, Matthias
    Kitz, Julia
    Michels, Beate
    Mekolli, Ardian
    Gaedcke, Jochen
    Hosseini, Ali Seif Amir
    Strobel, Philipp
    Ghadimi, Michael
    Ellenrieder, Volker
    Koenig, Alexander
    Koenig, Ute
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [6] Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and
    Gauci, Marie-Lea
    Baroudjian, Barouyr
    Bederede, Ulysse
    Zeboulon, Charlotte
    Delyon, Julie
    Allayous, Clara
    Madelaine, Isabelle
    Eftekhari, Pirayeh
    Resche-Rigon, Matthieu
    Pote, Nicolas
    Paradis, Valerie
    Durand, Francois
    Lebbe, Celeste
    Roux, Olivier
    Bouattour, Mohamed
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [7] Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse Events
    Rassy, Elie
    Pistilli, Barbara
    Robert, Caroline
    JAMA ONCOLOGY, 2021, 7 (10) : 1573 - 1574
  • [8] No need to hesitate: immune-related neutropenia and thrombocytopenia that improved by corticosteroids
    Kanai, Osamu
    Nakatani, Koichi
    Fujita, Kohei
    Okamura, Misato
    Mio, Tadashi
    RESPIROLOGY CASE REPORTS, 2021, 9 (07):
  • [9] Immune-Related Adverse Events Due to Cancer Immunotherapy
    Benesova, Karolina
    Leipe, Jan
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (06) : 535 - 543
  • [10] The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
    Coschi, Courtney H.
    Juergens, Rosalyn A.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4392 - 4407
12345